Introducing for the first time under the Advil
brand, a single tablet combining ibuprofen and
acetaminophen
MISSISSAUGA, ON, Aug. 3, 2022
/CNW/ - For more than three decades, Canadians have trusted Advil
to deliver relief from pain. New Advil PLUS Acetaminophen – from
Haleon (formerly GSK Consumer Healthcare), a leader in pain relief
– combines ibuprofen and acetaminophen to fight pain in two ways.
This is the first product brought to market by Haleon since
launching as an independent company focused entirely on consumer
healthcare.
No pain is the same, with 76 per cent of Canadian experiencing
some version of pain and, on average, experiencing three to
four different types1. Advil PLUS
Acetaminophen combines two of the most popular multi-indication
pain relievers in Canada, into one
convenient tablet, to help treat headaches, migraine pain, back,
muscle, joint, menstrual pain and fever.
"For decades, Canadians have been alternating or combining
ibuprofen and acetaminophen to help manage their pain, as per the
advice of healthcare professionals, though this has historically
been cautioned," said Dr. Nardine Nakhla, community pharmacist and
Clinical Lecturer at the University of
Waterloo School of Pharmacy. "We now have more literature to
support the combined use of ibuprofen and acetaminophen, and with
Advil combining these active ingredients into one product,
Canadians can choose an effective, non-prescription solution, that
helps manage some of the most common pain types in adults."
Advil PLUS Acetaminophen is a pain-fighting combination of
ibuprofen and acetaminophen—two distinct mechanisms of action that
fight pain in two ways.2 Ibuprofen is a nonsteroidal
anti-inflammatory (NSAID) that targets pain at the source and
decreases the synthesis of pain and inflammation
mediators.2,3 Acetaminophen, a non-NSAID analgesic, is
believed to exert its effects via COX inhibition in the central
nervous system and activation of central serotonergic
pathways.4,5
"The new treatment also provides clinicians with further
therapeutic options to help reduce the frequency and severity of
acute pain in adults," said Dr. Nakhla. "Advil PLUS Acetaminophen
is a valuable addition to the roster of pain treatments for
clinicians nationwide, offering up to eight hours of long-lasting
effective pain relief, with lower maximum daily doses of each
ingredient."
Advil PLUS Acetaminophen is indicated for fast and effective
temporary pain relief in adults over 18 years. It is now available
over the counter at pharmacies, grocery stores, and retailers
across Canada and online. Find
more information about Advil PLUS Acetaminophen at advil.ca.
Important safety information about
Advil PLUS Acetaminophen
Before using the product, consumers should read the Advil PLUS
Acetaminophen drug facts label and consumer medication leaflet.
About Haleon
Haleon (LSE: HLN) is a global leader in consumer health, with
brands trusted by millions of consumers globally. The group employs
over 22,000 people across 170 markets, who are united by Haleon's
purpose - to deliver better everyday health with humanity. Haleon's
product portfolio spans five major categories - Oral Health,
Pain Relief, Respiratory Health, Digestive Health and
Other, and Vitamins, Minerals and Supplements (VMS). Its
long-standing brands - such as Advil, Sensodyne, Voltaren,
Neocitran, Otrivin, Polident and Centrum - are built on trusted
science, innovation and deep human understanding.
For more information, please visit www.haleon.com
|
1. Pain
Management 2.0. Isobar. October, 2019. Data on file.
|
2. Advil PLUS Acetaminophen Health
Canada Product Monograph. GSK Consumer Healthcare ULC. March 4,
2021.
|
3. Tanner T, et al. The
pharamcokinetic profile of a novel fixed-dose combination tablet of
ibuprofen and paracetamol. BMC Clin Pharmacol.
2010;10:10.
|
4. Searle S et al. Efficacy and
safety of single and multiple doses of a fixeddose combination of
ibuprofen and acetaminophen in the treatment of postsurgical dental
pain. Clin J Pain. 2020 Apr 7. Vol published ahead of print:
doi:10.1097/
|
AJP.0000000000000828.
|
5. Tanner T, Aspley S, Munn A, Thomas
T. The pharmacokinetic profile of a novel fixed-dose combination
tablet of ibuprofen and paracetamol. BMC Clin Pharmacol. 2010 Jul
5;10:10. doi: 10.1186/1472-6904-10-10. PMID: 20602760; PMCID:
PMC2906415.
|
SOURCE Haleon